Patents Assigned to University College Dublin
-
Publication number: 20170349952Abstract: A method of determining the risk of metastatic prostate cancer in an individual diagnosed with prostate cancer, the method comprising a step of assaying a biological sample obtained from the individual for the presence of at last one methylated regulatory DNA sequence selected from group comprising: SEQUENCE ID No's 1 to 16, or variants thereof, and correlating the presence or absence of the methylated regulatory DNA sequence with aggressive (metastatic) prostate cancer.Type: ApplicationFiled: December 23, 2015Publication date: December 7, 2017Applicant: UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND, DUBLINInventor: Antoinette PERRY
-
Patent number: 9822375Abstract: Use of an isolated Ensifer adhaerens strain OV14 deposited under NCIMB Accession Number 4177, or an isolated variant thereof characterized by a 16S rRNA gene having at least 98.6% sequence homology with SEQUENCE ID NO: 1, as a gene delivery system in the genetic transformation of a plant cell or plant material is described.Type: GrantFiled: June 2, 2016Date of Patent: November 21, 2017Assignees: University College Dublin, National University of Ireland, Agriculture and Food Development Authority (“TEAGASC”)Inventors: Ewen Mullins, Toni Wendt, Fiona Doohan
-
Patent number: 9815788Abstract: (E)-2-(2-Quinolin-2-yl-propenyl)-phenol, 2-Quinolin-2-yl-ylethynyl-phenol and salts thereof are useful as medicaments, especially for treatment of an angiogenesis-related disease or disorder.Type: GrantFiled: June 28, 2016Date of Patent: November 14, 2017Assignees: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN, UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND, DUBLINInventors: Breandan Noel Kennedy, Alison Reynolds, Claire Kilty, Jacintha O'Sullivan, Andrew Douglas Baxter
-
Patent number: 9819953Abstract: A computer-implemented method, computer program product, and computing system is provided for decoding media streams. In an implementation, a method may include selecting a time window for monitoring discontinuities in a plurality of packets in a media transmission stream having a first time and a second time. The first time may indicate a beginning of the time window and the second time may indicate an end of the time window. The method may also include determining the number of discontinuities in the plurality of packets at the first time at a network node. The method may also include determining the number of discontinuities in the plurality of packets at the second time at the network node. The method may also include determining the number of discontinuities in the plurality of packets within the time window. The method may also include comparing the number of discontinuities within the time widow to a plurality of predefined discontinuities threshold values.Type: GrantFiled: December 31, 2013Date of Patent: November 14, 2017Assignees: International Business Machines Corporation, University College DublinInventors: Paul B. French, James P. Galvin, Jr., Patrick McDonagh, Patrick J. O'Sullivan
-
Patent number: 9738599Abstract: The invention generally relates to compounds that function as TP antagonists for treating thrombosis and other cardiovascular, renal, or pulmonary diseases. In some embodiments, the invention provides a compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating thrombosis by administering an antithrombotic compound that preferentially binds to a thromboxane receptor, has preferential binding for either TPalpha (TP?) or TPbeta (TP?) receptor subtype.Type: GrantFiled: March 16, 2017Date of Patent: August 22, 2017Assignee: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINInventors: B. Therese Kinsella, Patrick Guiry, Helen Reid, Barry O'Connor
-
Patent number: 9718781Abstract: The invention generally relates to methods and compounds for treating proliferative disorders, viral infections, or both. In some embodiments, the invention provides an anticancer or antiviral compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating a proliferative disorder or a viral infection including administering an anticancer or antiviral compound that binds to a thromboxane receptor, has preferential binding for either TPalpha (TP?) or TPbeta (TP?) receptor subtype.Type: GrantFiled: April 17, 2013Date of Patent: August 1, 2017Assignee: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINInventors: B. Therese Kinsella, Helen Reid
-
Patent number: 9675802Abstract: A method and apparatus for stimulating the lower back and abdominal muscles in a patient comprising applying a first electrode A1/A2 substantially centrally to the lower lumbar region of the patient's body, and applying second and third electrodes B, C respectively to opposite side flanks of the patient's body. The electrodes are energized to apply a first group of muscular stimulation current pulses which flow between the second and third electrodes and a second group of muscular stimulation current pulses which flow between the first electrode and the second and third electrodes alternately.Type: GrantFiled: June 16, 2010Date of Patent: June 13, 2017Assignees: University College Dublin, National University of Ireland, Dublin, Bio-Medical Research Ltd.Inventors: Louis Crowe, Brian Caulfield, Conor Minogue
-
Publication number: 20170146527Abstract: A method of labelling a target molecule forming part of a corona of molecules on a nanosized object is described. The method comprising the steps of incubating the nanosized object with a plurality of probes, in which the plurality of probes comprise small nanoparticles labelled with a recognition motif specific for the target molecule, separating the nanosized object and unbound probe. The invention also provides a method of determining the location or spatial distribution of a molecule forming part of a corona of molecules on the surface of a nanoparticle.Type: ApplicationFiled: June 17, 2015Publication date: May 25, 2017Applicant: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELANDInventors: Philip KELLY, Kenneth DAWSON
-
Patent number: 9641904Abstract: A first instance of a reference video is stored. A primary video and a second instance of the reference video are simultaneously received. At least one quality of experience value that infers a perceptual quality of the primary video as received by a system is generated by comparing the first instance of the reference video to the second instance of the reference video on a pixel-by-pixel, frame-by-frame, basis and determining whether each pixel and each frame contained in the first instance of the reference video are contained in the second instance of the reference video.Type: GrantFiled: March 25, 2016Date of Patent: May 2, 2017Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, UNIVERSITY COLLEGE DUBLINInventors: Jonathan Dunne, Paul B. French, James P. Galvin, Jr., Patrick McDonagh, Patrick J. O'Sullivan
-
Patent number: 9641905Abstract: A first instance of a reference video is stored. A primary video and a second instance of the reference video are simultaneously received. At least one quality of experience value that infers a perceptual quality of the primary video as received by a system is generated by comparing the first instance of the reference video to the second instance of the reference video on a pixel-by-pixel, frame-by-frame, basis and determining whether each pixel and each frame contained in the first instance of the reference video are contained in the second instance of the reference video.Type: GrantFiled: March 25, 2016Date of Patent: May 2, 2017Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, UNIVERSITY COLLEGE DUBLINInventors: Jonathan Dunne, Paul B. French, James P. Galvin, Jr., Patrick McDonagh, Patrick J. O'Sullivan
-
Patent number: 9630915Abstract: The invention generally relates to compounds that function as TP antagonists for treating thrombosis and other cardiovascular, renal, or pulmonary diseases. In some embodiments, the invention provides a compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating thrombosis by administering an antithrombotic compound that preferentially binds to a thromboxane receptor, has preferential binding for either TPalpha (TP?) or TPbeta (TP?) receptor subtype.Type: GrantFiled: November 11, 2016Date of Patent: April 25, 2017Assignee: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINInventors: B. Therese Kinsella, Patrick Guiry, Helen Reid, Barry O'Connor
-
Publication number: 20170050930Abstract: (E)-2-(2-Quinolin-2-yl-propenyl)-phenol, 2-Quinolin-2-yl-ylethynyl-phenol and salts thereof are useful as medicaments, especially for treatment of an angiogenesis-related disease or disorder.Type: ApplicationFiled: June 28, 2016Publication date: February 23, 2017Applicants: University College Dublin National University of Ireland, Dublin, The Provost, Fellows, Foundation Scholars, and the other members of Board, of the College of the HolInventors: Breandan Noel KENNEDY, Alison REYNOLDS, Claire KILTY, Jacintha O'SULLIVAN, Andrew Douglas BAXTER
-
Publication number: 20170010269Abstract: A method is provided for characterising and/or prognosing prostate cancer in a subject comprising measuring the level of at least one protein from a panel or at least one peptide thereof in a sample from the subject. The method may be used to determine the grade and stage of the prostate cancer. Also disclosed is a method for selecting a treatment for prostate cancer, together with corresponding methods of treatment. Systems and computing devices for performing the methods are also provided.Type: ApplicationFiled: December 19, 2014Publication date: January 12, 2017Applicant: University College Dublin, National University of Ireland, DublinInventors: Stephen Pennington, Brendan Murphy, William Watson
-
Patent number: 9522877Abstract: The invention generally relates to compounds that function as TP antagonists for treating thrombosis and other cardiovascular, renal, or pulmonary diseases. In some embodiments, the invention provides a compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating thrombosis by administering an antithrombotic compound that preferentially binds to a thromboxane receptor, has preferential binding for either TPalpha (TP?) or TPbeta (TP?) receptor subtype.Type: GrantFiled: June 10, 2016Date of Patent: December 20, 2016Assignee: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINInventors: B. Therese Kinsella, Patrick Guiry, Helen Reid, Barry O'Connor
-
Publication number: 20160326122Abstract: Compounds and compositions are described which are useful especially for treatment of angiogenesis-related diseases or disorders such as neovascularisation of the eye, age-related macular degeneration, diabetic retinopathy or cancer.Type: ApplicationFiled: January 15, 2015Publication date: November 10, 2016Applicants: UNIVERSITY COLLEGE DUBLIN - NATIONAL UNIVERSITY OF IRELAND, DUBLIN, THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETHInventors: Breandan KENNEDY, Alison REYNOLDS, Jacintha O'SULLIVAN, Andrew Douglas BAXTER
-
Patent number: 9451650Abstract: A first mobile device receives, from each of a plurality of other mobile devices, information related to the availability of at least one network resource provided by at least a first network offered for sharing by the respective other mobile device. The first mobile device also receives a request from a second mobile device to access the network resource provided by the first network shared by at least one of the plurality of other mobile devices. The first mobile device selects at least one of the other mobile devices to share the network resource provided by the first network with the second mobile device. The first mobile device communicates to the second mobile device peer-to-peer network connection information of the selected at least one of the other mobile devices.Type: GrantFiled: November 23, 2015Date of Patent: September 20, 2016Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, UNIVERSITY COLLEGE DUBLIN, BELFIELDInventors: Jonathan Dunne, Paul B. French, James P. Galvin, Jr., Yi Han, Patrick J. O'Sullivan
-
Patent number: 9421555Abstract: A flow enhanced method and system for flow non-linear magnetophoresis (F-NLM) is described. By tuning an external field frequency and the flow rate the migration velocities of different bead types may be caused to differ by several orders of magnitude over an extended range of frequencies to allow for separation of particles. Use of such efficiency in separation in bio-separation and similar assays is described.Type: GrantFiled: July 7, 2011Date of Patent: August 23, 2016Assignee: University College Dublin, National University of IrelandInventors: Gil Lee, Peng Li, Mark Platt, Gemma Cannon
-
Patent number: 9388138Abstract: (E)-2-(2-Quinolin-2-yl-propenyl)-phenol, 2-Quinolin-2-yl-ylethynyl-phenol and salts thereof are useful as medicaments, especially for treatment of an angiogenesis-related disease or disorder.Type: GrantFiled: July 15, 2013Date of Patent: July 12, 2016Assignees: UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND, DUBLIN, THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMEBERS OF BOARD, OF THE COLLEGES OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLINInventors: Breandan Douglas Kennedy, Alison Reynolds, Claire Kilty, Jacintha O'Sullivan, Andrew Douglas Baxter
-
Patent number: 9388127Abstract: The invention generally relates to compounds that function as TP antagonists for treating thrombosis and other cardiovascular, renal, or pulmonary diseases. In some embodiments, the invention provides a compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating thrombosis by administering an antithrombotic compound that preferentially binds to a thromboxane receptor, has preferential binding for either TPalpha (TP?) or TPbeta (TP?) receptor subtype.Type: GrantFiled: April 17, 2013Date of Patent: July 12, 2016Assignee: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINInventors: B. Therese Kinsella, Patrick Guiry, Helen Reid, Barry O'Connor
-
Patent number: 9365858Abstract: Use of an isolated Ensifer adhaerens strain OV14 deposited under NCIMB Accession Number 4177, or an isolated variant thereof characterized by a 16S rRNA gene having at least 98.6% sequence homology with SEQUENCE ID NO: 1, as a gene delivery system in the genetic transformation of a plant cell or plant material is described.Type: GrantFiled: December 23, 2010Date of Patent: June 14, 2016Assignee: UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELANDInventors: Ewen Mullins, Toni Wendt, Fiona Doohan